Articles published by Kiromic BioPharma, Inc.
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
KRBP
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20240424199583/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240402903280/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240319287248/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240301490403/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240228415761/en/832027/5/Kiromic_LOGO_v2.jpg)
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
February 28, 2024
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20240214056810/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240129301996/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20240105590033/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20231214862515/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20231116446922/en/832027/5/Kiromic_LOGO_v2.jpg)
Kiromic BioPharma Announces Uplisting to OTCQB Market
November 16, 2023
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20231023260123/en/832027/5/Kiromic_LOGO_v2.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230724242742/en/832027/5/Kiromic_LOGO_v2.jpg)
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20230501005246/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20230403005088/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20230310005330/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20230228005440/en/832027/5/Kiromic_LOGO_v2.jpg)
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20230223005784/en/832027/5/Kiromic_LOGO_v2.jpg)
![](https://mms.businesswire.com/media/20230216005334/en/832027/5/Kiromic_LOGO_v2.jpg)
Kiromic BioPharma CEO Issues Letter to Stockholders
February 16, 2023
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20221027005642/en/832027/5/Kiromic_LOGO_v2.jpg)
Kiromic BioPharma Arranges Up to $10 Million Financing
October 27, 2022
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20221006005406/en/832027/5/Kiromic_LOGO_v2.jpg)
Kiromic BioPharma Announces FDA Feedback from Type B Pre-IND Meeting Confirms Deltacel Development Strategy
October 06, 2022
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20220712005537/en/1510842/4/Kiromic_Logo.jpg)
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20220707005261/en/830853/5/Kiromic_Logo.jpg)
![](https://mms.businesswire.com/media/20220621005352/en/830853/5/Kiromic_Logo.jpg)
Via Business Wire
Tickers
KRBP
![](https://mms.businesswire.com/media/20220607005593/en/1478433/5/Kiromic_LOGO_v2.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.